Ribavirin modulates the conversion of human CD4+ CD25−T cell to CD4+ CD25+ FOXP3+T cell via suppressing interleukin-10-producing regulatory T cell-Reference-Cited by-同舟云学术

Ribavirin modulates the conversion of human CD4+ CD25−T cell to CD4+ CD25+ FOXP3+T cell via suppressing interleukin-10-producing regulatory T cell

Published:2012-10-02 Issue:3 Volume:137 Page:259-270
ISSN:0019-2805
Container-title:Immunology
language:en
Short-container-title:Immunology

Author:

Kobayashi Tamaki¹,Nakatsuka Katsuhisa¹,Shimizu Masumi²,Tamura Hideto³,Shinya Eiji²,Atsukawa Masanori¹,Harimoto Hirotomo,Takahashi Hidemi²,Sakamoto Choitsu¹

Affiliation:

1. Division of Gastroenterology; Department of Internal Medicine; Nippon Medical School; Tokyo; Japan

2. Division of Microbiology and Immunology; Nippon Medical School; Tokyo; Japan

3. Division of Haematology; Department of Internal Medicine; Nippon Medical School; Tokyo; Japan

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/imm.12005/fullpdf

Reference66 articles.

1. Regulatory T cells and inhibitory cytokines in autoimmunity;Bettini;Curr Opin Immunol,2009

2. Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes?;Bui;Curr Opin Immunol,2007

3. Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages;Rosen;Hepatology,2002

4. Immunosuppressive strategies that are mediated by tumor cells;Rabinovich;Annu Rev Immunol,2007

5. Chronic hepatitis C: T-helper1/T-helper2 imbalance could cause virus persistence in peripheral blood;Osna;Scand J Clin Lab Invest,1997

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction and surveillance of de novo HCC in patients with compensated advanced chronic liver disease after hepatitis C virus eradication with direct antiviral agents;Frontiers in Virology;2023-10-24

2. Hantavirus: an overview and advancements in therapeutic approaches for infection;Frontiers in Microbiology;2023-10-12

3. Treatment and therapeutic agents;Coronavirus Disease;2022

4. The Impact of Steatosis on Chronic Hepatitis C Progression and Response to Antiviral Treatments;Biomedicines;2021-10-17

5. Repurposed Antiviral Drugs for the Treatment of COVID-19: Syntheses, Mechanism of Infection and Clinical Trials;Mini-Reviews in Medicinal Chemistry;2021-05-19